HCC
CYTR

Hirtle Callaghan & Co’s CytRx Corp CYTR Stock Holding History

Hirtle Callaghan & Co’s Portfolio CYTR Stock Details CYTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-43
Closed -$1K – 486
2014
Q4 		$1K Buy
+43
New +$671 ﹤0.01% 565
2014
Q3 		– Sell
-43
Closed -$1K – 661
2014
Q2 		$1K Hold
43
– – ﹤0.01% 642
2014
Q1 		$1K Hold
43
– – ﹤0.01% 628
2013
Q4 		$2K Hold
43
– – ﹤0.01% 559
2013
Q3 		$1K Hold
43
– – ﹤0.01% 616
2013
Q2 		$1K Buy
+43
New +$634 0.01% 60

Other funds holding CYTR

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Hirtle Callaghan & Co's CYTR Position: Q1 2015 in Review

Hirtle Callaghan & Co sold out of CytRx Corp (CYTR) in Q1 2015, closing a stake of 43 shares — an estimated $1K sold.

Hirtle Callaghan & Co first reported a position in CYTR in Q2 2013 and held it in 6 quarters. The position peaked at $2K in Q4 2013. 64 funds tracked by Wall St. Rank hold CYTR as of Q1 2015.

  • Hirtle Callaghan & Co reported no remaining CytRx Corp position as of Q1 2015 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 43 CytRx Corp shares in Q1 2015, an estimated $1K.
  • Hirtle Callaghan & Co first reported a position in CytRx Corp in Q2 2013 and held it in 6 quarters.
  • Hirtle Callaghan & Co's CytRx Corp position peaked at $2K in Q4 2013.
  • 64 funds tracked by Wall St. Rank held CytRx Corp as of Q1 2015.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2015, filed 15 May 2015.